Today: 25 April 2026
Nebius stock tumbles 10% into weekend as Feb 12 earnings turns into next test for NBIS
31 January 2026
2 mins read

Nebius stock tumbles 10% into weekend as Feb 12 earnings turns into next test for NBIS

New York, Jan 31, 2026, 05:33 (EST) — Market closed

  • On Friday, NBIS plunged 10.2%, ending the day at $85.19.
  • Nebius scheduled its fourth-quarter and full-year 2025 results for Feb. 12, with an 8 a.m. ET call planned.
  • The decline followed a slide in U.S. stocks, rattled by concerns over rates and AI spending.

Shares of Nebius Group N.V. (NBIS) dropped 10.2% Friday, closing at $85.19 after trading as high as $94.11 and as low as $84.19. Roughly 18.2 million shares were traded.

With U.S. markets closed for the weekend, all eyes turn to Feb. 12. That’s when Nebius will release its Q4 and full-year 2025 earnings before the open, followed by a conference call at 8:00 a.m. Eastern. The Amsterdam-based company trades on Nasdaq and specializes in full-stack AI infrastructure. It also runs Avride and TripleTen, alongside stakes in ClickHouse and Toloka.

Timing played a key role as risk appetite dipped heading into month-end. Wall Street’s major indexes ended Friday lower after investors digested President Donald Trump’s choice of ex-Fed governor Kevin Warsh and a hotter inflation report. “Markets are calibrating” to the nomination and the outlook on rates, said Michael Hans, chief investment officer at Citizens Wealth. Reuters

Thursday saw a rough ride for tech and software stocks as doubts grew over whether Big Tech’s AI spending will pay off. Microsoft tumbled 10% after cloud revenue came up short, prompting John Praveen of Paleo Leon to warn, “there are some genuine concerns that AI investments will eat the software companies’ lunches.” Reuters

Spending on AI infrastructure keeps climbing. Meta now forecasts 2026 capex—cash poured into data centers and gear—between $115 billion and $135 billion. The company also inked capacity deals with Nebius and CoreWeave. “This is going to be a big year,” CEO Mark Zuckerberg said. Reuters

For Nebius, the trade is that split-screen. Investors demand clear evidence that growth is solid and lasting, yet they slam any sign of unchecked spending or delayed returns.

Nebius has pinned its growth hopes on multi-year contracts, revealing last year it inked a roughly $3 billion deal with Meta and another $17.4 billion agreement with Microsoft to supply AI infrastructure capacity. The company also flagged steep spending on graphics processing units (GPUs)—the chips powering AI training and operations—and mounting losses as it scales up its capacity.

Management described the build as gearing up for a prolonged cycle, not a rapid turnaround. Roman Chernin told Reuters in December the company is focused on developing higher-margin services and said, “We should be ready (for when) the winter will come.” Reuters

Still, the situation works both ways. Should February numbers reveal steady demand alongside surging spending, or if prices tighten amid growing capacity, the stock could remain fragile.

As next week unfolds, eyes turn to whether NBIS can steady itself following Friday’s sharp sell-off and if the wider AI sector regains momentum. Investors are still parsing the Fed chair nomination alongside fresh signals from Big Tech spending.

Nebius’s Feb. 12 results and conference call stand as the next major catalyst. Investors will zero in on any fresh clues about demand, the speed of the buildout, and how quickly capex converts into revenue.

Stock Market Today

  • TSX Stock Poised for 22% Upside as Alternative Energy Gains Amid U.S.-Israel-Iran Conflict
    April 24, 2026, 6:03 PM EDT. David Rosenberg of Rosenberg Research highlights a rebound in alternative energy stocks due to the U.S.-Israel-Iran tensions. The conflict reinforces energy security as a crucial priority, easing negative sentiment around clean energy. Investors are advised to manage geopolitical risks within portfolios rather than making hasty trades. Opportunities span beyond energy generation to batteries, grid modernization, and energy storage. Commodities linked to renewables include copper, uranium, lithium, nickel, and rare earth metals. Rosenberg recommends ETFs such as IBAT, ICLN, COPX, BASE, CPCC, REMX, and URA for exposure. The iShares Global Clean Energy ETF (ICLN) has surged nearly 10% since the conflict began. These developments present renewable energy not only as a growth area but also as a diversifier and hedge for investors.

Latest article

Corning Incorporated Just Opened a Financing Door After Its AI Stock Surge

Corning Incorporated Just Opened a Financing Door After Its AI Stock Surge

25 April 2026
Corning filed an automatic shelf registration late Friday, allowing it to offer debt and equity securities in the future. The move comes as GLW shares hit $179.08 intraday before closing at $175.89, ahead of its April 28 earnings call. The filing did not specify an offering size. Corning has recently secured a multi-billion dollar fiber-optic deal with Meta Platforms and plans to expand capacity in North Carolina.
Magnachip Semiconductor Stock Jumps 23% as New BatteryFET Puts Q1 Earnings in Focus

Magnachip Semiconductor Stock Jumps 23% as New BatteryFET Puts Q1 Earnings in Focus

24 April 2026
Magnachip Semiconductor’s U.S.-listed shares jumped 23% late Friday to $5.25 ahead of its April 28 earnings report. The company this week launched two 8th-generation 12V MOSFETs for smartphone battery protection, with one already in mass production for a major global smartphone maker. Magnachip has guided for Q1 revenue of $44–$48 million and a gross margin of 14–16%. Analysts expect a loss of 22 cents per share.
HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors

HCA Healthcare Stock Drops Despite Profit Beat As Weak Volumes Rattle Investors

24 April 2026
HCA Healthcare shares dropped 8.8% to $432.46 after first-quarter profit narrowly beat estimates but showed weaker patient volumes and payer-mix concerns. Revenue rose 4.3% to $19.1 billion, net income hit $1.62 billion, and adjusted EBITDA climbed 1.9% to $3.8 billion. Respiratory admissions fell 42% year-over-year. HCA reaffirmed its 2026 financial guidance.
Shopify stock slides nearly 9% as Fed-chair jitters build ahead of Feb. 11 earnings
Previous Story

Shopify stock slides nearly 9% as Fed-chair jitters build ahead of Feb. 11 earnings

Novavax stock drops 6% into the weekend as Pfizer Matrix‑M cash and earnings clock loom
Next Story

Novavax stock drops 6% into the weekend as Pfizer Matrix‑M cash and earnings clock loom

Go toTop